- Introduction
- Mechanism of action:
- inhibition of NaCl
reabsorption in the thick ascending limb
of the loop of Henle
- inhibit the Na/K/2Cl
transport system in the luminal
membrane
- reduction
in sodium chloride
reabsorption
- decreases
normal lumen-positive
potential (secondary to
potassium recycling)
- Positive
lumen potential: drives
divalent cationic
reabsorption (calcium
magnesium)
- Therefore,
loop diuretics increase
magnesium and calcium
excretion.
- hypomagnesemia
may occur in some
patients.
- hypocalcemia
does not usually develop
because calcium is
reabsorbed in the distal
convoluted tubule.
- {in
circumstances that result
in hypercalcemia, calcium
excretion can be enhanced
by administration of loop
diuretics with saline
infusion}
- Since a
significant percentage of filtered NaCl
is absorbed by the thick ascending limb
of loop of Henle, diuretics acting at
this site are highly effective
-
Loop
diuretics--Properties: rapidly absorbed following oral
administration (may be administered by IV)
- acts rapidly
- eliminated by a renal
secretion and glomerular filtration
(half-life -- depend on renal function)
- co-administration of drugs
that inhibit weak acid secretion (e.g.
probenecid or indomethacin) may alter
loop diuretic clearance.
- Other effects:
- Furosemide:
increases renal blood flow; blood
flow redistribution within the
renal cortex
- Furosemide decreases
pulmonary congestion and the left
ventricular filling pressure in
congestive heart failure (CHF) --
prior to an increase in urine
output.
- Clinical Uses:
-
Major uses:
- Other uses:
- Reduction of Intracranial Pressure
- hyperkalemia:
- loop diuretics increase potassium
excretion
- effect increased by concurrent
administration of NaCl and water.
- acute renal failure:
- may increase rate of urine flow and
increase potassium excretion.
- may convert oligouric to non-oligouric
failure {easier clinical management}
- renal failure duration -- not
affected
- anion overload:
- bromide, chloride, iodide: all
reabsorbed by the thick ascending loop:
- systemic toxicity may be reduced by
decreasing reabsorption
- concurrent administration of
sodium chloride and fluid is required to prevent
volume depletion
- Toxicity:
- Hypokalemia metabolic alkalosis:
- increased delivery
of NaCl and water to the
collecting duct increases
potassium and proton secretion--
causing a hypokalemic metabolic
alkalosis
- in managed by
potassium replacement and by
ensuring adequate fluid intake
- Ototoxicity:
- dose-related
hearing loss (in usually
reversible)
- ototoxicity more
common:
- with
decreased renal function
- with
concurrent administration
of other ototoxic drugs
such as aminoglycosides
- Hyperuricemia:
- may cause gout
- loop diuretics
cause increased uric acid
reabsorption in the proximal
tubule, secondary to hypovolemic
states.
- Hypomagnesemia: loop diuretics cause:
- reduction in
sodium chloride reabsorption
- decreases normal
lumen-positive potential
(secondary to potassium
recycling)
- Positive lumen
potential: drives divalent
cationic reabsorption (calcium
magnesium)
- Therefore, loop
diuretics increase magnesium and
calcium excretion.
- hypomagnesemia
may occur in some
patients.
- reversed
by oral magnesium
administration
- Allergic
reactions:
- furosemide: skin
rash, eosinophilia, interstitial
nephritis(less often)
- Other toxicities:
- Dehydration
(may be severe)
- hyponatremia
(less common than with
thiazides thought may occur in
patients who increased water
intake in response to a
hypovolemic thirst)
- Hypercalcemia may
occur in severe dehydration and
if a hypercalcemia condition
{e.g. oat cell long carcinoma} is
also present.
return to main menu
|